SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
---|---|---|---|---|---|---|---|---|---|
18-Nov-24 4:05 PM View: | Armen Garo H See Remarks Director | Antigenics Inc. (AGEN) | 15-Nov-24 | Grant | 5,997 | $2.72 | $16,311.80 | 4% 162.57K to 168.57K | |
04-Nov-24 11:10 AM View: | Armen Garo H See Remarks Director | Antigenics Inc. (AGEN) | 01-Nov-24 | Grant | 4,207 | $4.05 | $17,038.40 | 3% 158.37K to 162.57K | |
24-Sep-24 10:43 AM View: | Armen Garo H See Remarks Director | Antigenics Inc. (AGEN) | 20-Sep-24 | Grant | 2,793 | $5.84 | $16,311.10 | 2% 148.88K to 151.67K | |
09-Sep-24 3:32 PM View: | Armen Garo H See Remarks Director | Antigenics Inc. (AGEN) | 06-Sep-24 | Grant | 3,295 | $4.95 | $16,310.20 | 2% 145.58K to 148.88K | |
27-Aug-24 9:18 AM View: | Armen Garo H See Remarks Director | Antigenics Inc. (AGEN) | 23-Aug-24 | Grant | 2,982 | $5.47 | $16,311.50 | 2% 142.6K to 145.58K | |
12-Aug-24 4:54 PM View: | Armen Garo H See Remarks Director | Antigenics Inc. (AGEN) | 09-Aug-24 | Grant | 3,204 | $5.09 | $16,308.40 | 2% 139.4K to 142.6K | |
29-Jul-24 3:10 PM View: | Armen Garo H See Remarks Director | Antigenics Inc. (AGEN) | 26-Jul-24 | Grant | 2,486 | $6.56 | $16,308.20 | 2% 136.91K to 139.4K | |
15-Jul-24 10:54 AM View: | Armen Garo H See Remarks Director | Antigenics Inc. (AGEN) | 12-Jul-24 | Grant | 1,046 | $15.60 | $16,317.60 | < 1% 135.86K to 136.91K | |
18-Jun-24 2:45 PM View: | Armen Garo H See Remarks Director | Antigenics Inc. (AGEN) | 14-Jun-24 | Grant | 1,055 | $15.46 | $16,310.30 | < 1% 133.84K to 134.89K | |
03-Jun-24 2:09 PM View: | Armen Garo H See Remarks Director | Antigenics Inc. (AGEN) | 31-May-24 | Grant | 1,040 | $15.69 | $16,317.60 | < 1% 132.79K to 133.84K | |
20-May-24 12:49 PM View: | Armen Garo H See Remarks Director | Antigenics Inc. (AGEN) | 17-May-24 | Grant | 1,502 | $10.86 | $16,311.70 | 1% 131.29K to 132.79K | |
07-May-24 9:43 AM View: | Armen Garo H See Remarks Director | Antigenics Inc. (AGEN) | 03-May-24 | Grant | 1,248 | $13.07 | $16,311.40 | < 1% 130.04K to 131.29K | |
22-Apr-24 1:06 PM View: | Armen Garo H See Remarks Director | Antigenics Inc. (AGEN) | 19-Apr-24 | Grant | 3,080 | $5.31 | $16,354.80 | 2% 126.97K to 130.04K | |
08-Apr-24 2:59 PM View: | Armen Garo H See Remarks Director | Antigenics Inc. (AGEN) | 05-Apr-24 | Grant | 32,697 | $0.50 | $16,348.50 | 1% 2.51M to 2.54M | |
25-Mar-24 9:21 AM View: | Armen Garo H See Remarks Director | Antigenics Inc. (AGEN) | 22-Mar-24 | Grant | 27,163 | $0.55 | $14,939.70 | 1% 2.48M to 2.51M | |
11-Mar-24 4:39 PM View: | Armen Garo H See Remarks Director | Antigenics Inc. (AGEN) | 08-Mar-24 | Grant | 22,136 | $0.67 | $14,831.10 | < 1% 2.46M to 2.48M | |
27-Feb-24 8:57 AM View: | Armen Garo H See Remarks Director | Antigenics Inc. (AGEN) | 23-Feb-24 | Grant | 21,815 | $0.68 | $14,834.20 | < 1% 2.44M to 2.46M | |
15-Feb-24 6:59 PM View: | Armen Garo H See Remarks Director | Antigenics Inc. (AGEN) | 15-Feb-24 | Private Purchase | 500,000 | $0.65 | $324,050.00 | 26% 1.94M to 2.44M | |
12-Feb-24 1:50 PM View: | Armen Garo H See Remarks Director | Antigenics Inc. (AGEN) | 09-Feb-24 | Grant | 19,778 | $0.75 | $14,833.50 | 1% 1.92M to 1.94M | |
29-Jan-24 12:28 PM View: | Armen Garo H See Remarks Director | Antigenics Inc. (AGEN) | 26-Jan-24 | Grant | 22,475 | $0.66 | $14,833.50 | 1% 1.89M to 1.92M | |
16-Jan-24 4:19 PM View: | Armen Garo H See Remarks Director | Antigenics Inc. (AGEN) | 12-Jan-24 | Grant | 23,177 | $0.64 | $14,833.30 | 1% 2.12M to 2.14M | |
03-Jan-24 11:03 AM View: | Armen Garo H See Remarks Director | Antigenics Inc. (AGEN) | 29-Dec-23 | Grant | 23,453 | $0.83 | $19,466.00 | 1% 2.1M to 2.12M | |
18-Dec-23 11:43 AM View: | Armen Garo H See Remarks Director | Antigenics Inc. (AGEN) | 15-Dec-23 | Grant | 23,453 | $0.69 | $16,182.60 | 1% 2.08M to 2.1M | |
04-Dec-23 8:57 AM View: | Armen Garo H See Remarks Director | Antigenics Inc. (AGEN) | 01-Dec-23 | Grant | 20,727 | $0.78 | $16,167.10 | 1% 2.06M to 2.08M | |
20-Nov-23 9:29 AM View: | Armen Garo H See Remarks Director | Antigenics Inc. (AGEN) | 17-Nov-23 | Grant | 23,511 | $0.69 | $16,222.60 | 1% 2.03M to 2.06M | |
12-Feb-24 10:00 PM View: | Hirsch Susan B Director | Antigenics Inc. (AGEN) | 15-Nov-23 | Acquisition (small) | 5,000 | $0.75 | $3,750.00 | 4% 113.72K to 118.72K | |
17-Nov-23 4:22 PM View: | Wiinberg Ulf Director | Antigenics Inc. (AGEN) | 15-Nov-23 | Private Purchase | 25,000 | $0.76 | $19,000.00 | 25% 99.06K to 124.06K | |
12-Feb-24 10:00 PM View: | Hirsch Susan B Director | Antigenics Inc. (AGEN) | 14-Nov-23 | Acquisition (small) | 5,000 | $0.67 | $3,350.00 | 5% 108.72K to 113.72K | |
06-Nov-23 8:44 AM View: | Armen Garo H See Remarks Director | Antigenics Inc. (AGEN) | 03-Nov-23 | Grant | 19,200 | $0.84 | $16,128.00 | < 1% 2.01M to 2.03M | |
12-Feb-24 10:00 PM View: | Wright Timothy Director | Antigenics Inc. (AGEN) | 03-Nov-23 | Acquisition (small) | 5,000 | $0.88 | $4,400.00 | 10% 50.39K to 55.39K | |
23-Oct-23 10:58 AM View: | Armen Garo H See Remarks Director | Antigenics Inc. (AGEN) | 20-Oct-23 | Grant | 18,142 | $0.89 | $16,146.40 | < 1% 2.0M to 2.01M | |
10-Oct-23 9:00 AM View: | Armen Garo H See Remarks Director | Antigenics Inc. (AGEN) | 06-Oct-23 | Grant | 15,305 | $1.06 | $16,223.30 | < 1% 1.98M to 2.0M | |
25-Sep-23 12:42 PM View: | Armen Garo H See Remarks Director | Antigenics Inc. (AGEN) | 22-Sep-23 | Grant | 13,888 | $1.18 | $16,387.80 | < 1% 1.97M to 1.98M | |
11-Sep-23 9:01 AM View: | Armen Garo H See Remarks Director | Antigenics Inc. (AGEN) | 08-Sep-23 | Grant | 13,145 | $1.23 | $16,168.40 | < 1% 1.95M to 1.97M | |
09-Jan-23 5:42 PM View: | O'Day Steven J Chief Medical Officer | Antigenics Inc. (AGEN) | 05-Jan-23 | Grant | 109,381 | $2.45 | $267,983.00 | 67% 163.0K to 272.38K | |
09-Jan-23 5:48 PM View: | Klaskin Christine M PFO & PAO | Antigenics Inc. (AGEN) | 05-Jan-23 | Grant | 31,294 | $2.45 | $76,670.30 | 26% 122.64K to 153.94K | |
09-Jan-23 6:03 PM View: | Armen Garo H Chairman and CEO Director | Antigenics Inc. (AGEN) | 05-Jan-23 | Grant | 241,383 | $2.45 | $591,388.00 | 14% 1.71M to 1.95M | |
04-Jan-23 11:20 AM View: | Hirsch Susan B Director | Antigenics Inc. (AGEN) | 03-Jan-23 | Grant | 7,239 | $2.59 | $18,749.00 | 7% 101.49K to 108.72K | |
05-Oct-22 1:05 PM View: | Hirsch Susan B Director | Antigenics Inc. (AGEN) | 03-Oct-22 | Grant | 7,216 | $2.60 | $18,747.20 | 8% 94.27K to 101.49K | |
06-Jul-22 3:51 PM View: | Hirsch Susan B Director | Antigenics Inc. (AGEN) | 01-Jul-22 | Grant | 10,138 | $1.85 | $18,755.30 | 12% 84.13K to 94.27K | |
04-Feb-22 5:50 PM View: | O'Day Steven J Chief Medical Officer | Antigenics Inc. (AGEN) | 02-Feb-22 | Grant | 101,682 | $2.51 | $255,222.00 | 166% 61.32K to 163.0K | |
04-Feb-22 5:50 PM View: | Klaskin Christine M PFO & PAO | Antigenics Inc. (AGEN) | 02-Feb-22 | Grant | 29,587 | $2.51 | $74,263.40 | 32% 93.06K to 122.64K | |
04-Feb-22 5:50 PM View: | Armen Garo H Chairman and CEO Director | Antigenics Inc. (AGEN) | 02-Feb-22 | Grant | 237,011 | $2.51 | $594,898.00 | 16% 1.48M to 1.71M | |
06-Jan-22 5:47 PM View: | O'Day Steven J Chief Medical Officer | Antigenics Inc. (AGEN) | 06-Jan-22 | Market Option Sale | 38,679 | $3.06 | $118,346.00 | (39%) 100.0K to 61.32K | |
06-Jan-22 5:47 PM View: | O'Day Steven J Chief Medical Officer | Antigenics Inc. (AGEN) | 04-Jan-22 | Option Exercise | 100,000 | -- | -- | 100% 0 to 100.0K | |
05-Jan-22 2:59 PM View: | Hirsch Susan B Director | Antigenics Inc. (AGEN) | 03-Jan-22 | Grant | 4,677 | $4.01 | $18,754.80 | 28% 16.89K to 21.57K | |
05-Oct-21 7:18 PM View: | Hirsch Susan B Director | Antigenics Inc. (AGEN) | 01-Oct-21 | Grant | 3,257 | $5.76 | $18,760.30 | 24% 13.64K to 16.89K | (5%) |
14-Sep-21 5:30 PM View: | Armen Garo H Chairman and CEO Director | Antigenics Inc. (AGEN) | 13-Sep-21 | Option Exercise | 119,178 | $3.36 | $400,438.00 | 8% 1.44M to 1.56M | |
14-Sep-21 5:30 PM View: | Armen Garo H Chairman and CEO Director | Antigenics Inc. (AGEN) | 13-Sep-21 | Market Option Sale | 82,107 | $6.50 | $533,696.00 | (5%) 1.56M to 1.48M | |
14-Sep-21 5:30 PM View: | Klaskin Christine M PFO & PAO | Antigenics Inc. (AGEN) | 10-Sep-21 | Option Exercise | 16,563 | $3.36 | $55,651.70 | 19% 87.61K to 104.18K |